News

Video: Global Fund Impact in Indonesia

The Global Fund to fight AIDS, Tuberculosis and Malaria has had a positive impact in Indonesia helping the country leverage local and national funding for its programmes. The video presents interviews with a diverse range of stakeholders and touches on issues around financial accountability, the need for programme implementers to have more training to manage TB, HIV or malaria programs, raises fears of people living with HIV about starting on anti-retroviral therapy and adhering to treatment and presents views on the scaling up treatment to meet MDGs targets.

Another perspective from Kenya:

Spotlight: Mixed perceptions of the Global Fund in Kenya by Henry Neondo, Kenya

Funding for health should begin targeting prevention programmes that address issues that affect women and children, and the Global Fund to fight HIV/AIDS, TB and Malaria (The Global Fund) has a key role to play.

In the context of HIV, Professor Alloys Orago, Director of the National AIDS Control Council (NACC), says “for every one person put on treatment, two more get newly infected – women and the youth still bearing the brunt of the three most burdened some diseases: HIV, tuberculosis and malaria.”

For full text to article by , click here.

More News
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...
5 Jun 2019
**Update: The US FDA Antimicrobial Drug Advisory Committee voted in favor of the NDA 14 to 4 on June 6th, 2019** The United States Food & Drug Administration (FDA) will host the Antimicrobial Drug Advisory Committee on Thursday, June 6th to discuss the new drug application (NDA) involving new...